61The differences in treatment permitted by Article 65(1)(a) TFEU must not constitute, according to Article 65(3), a means of arbitrary discrimination or a disguised restriction. The Court has held, consequently, that such differences in treatment are permitted only when they concern situations which are not objectively comparable or, otherwise, when they are justified by an overriding reason in the public interest (see, to that effect, judgments of 6 June 2000, Verkooijen, C‑35/98, EU:C:2000:294, paragraph 43; of 7 September 2004, Manninen, C‑319/02, EU:C:2004:484, paragraph 29; and of 17 September 2009, Glaxo Wellcome, C‑182/08, EU:C:2009:559, paragraph 68).
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.